<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:120px; width:175px; height:20px;"><span style="font-family: ABCDEE+MV Boli; font-size:20px">Invited Speakers 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:143px; width:161px; height:25px;"><span style="font-family: Arial; font-size:7px"> 
<br></span><span style="font-family: Arial,Bold; font-size:14px">Wednesday, June 10 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:162px; top:171px; width:394px; height:128px;"><span style="font-family: Arial; font-size:9px"> 
<br></span><span style="font-family: Arial,Bold; font-size:11px">Jordi Salas-Salvadó, MD, PhD</span><span style="font-family: Arial; font-size:9px"> 
<br>Human Nutrition Unit, Department of Biochemistry &amp; Biotechnology, Sant Joan 
<br>University Hospital, Faculty of Medicine of Reus, Rovira i Virgili University, Spain; Pere 
<br>Virgili Institute of Health Research; CIBER </span><span style="font-family: Arial; font-size:10px">Physiopathology of Obesity and Nutrition, 
<br>Institute of Health Carlos III, Spain. Dr Salas Salvadó</span><span style="font-family: Arial; font-size:9px"> is Professor of Human 
<br>Nutrition and Bromatology at the Faculty of Medicine and Health Sciences (Rovira i 
<br>Virgili University).  He is Head of Nutrition of the Internal Medicine Service, Sant Joan 
<br>University Hospital of Reus and Vice-Dean / Head of Studies of the Degree in Human 
<br>Nutrition and Dietetics of the Rovira i Virgili University.  He is also Distinguished 
<br>Professor at the Universitat Rovira i Virgili.  In recent years, the expertise and research 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:302px; width:500px; height:385px;"><span style="font-family: Arial; font-size:9px">lines of Dr Salas are focused on human clinical trials evaluating the effect of diets and dietary compounds on 
<br>obesity, type 2 diabetes mellitus, metabolic syndrome and cardiovascular disease. Since 2005, he has been one 
<br></span><span style="font-family: Arial; font-size:9px">of the leaders of PREDIMED STUDY, considered the best clinical trial evaluating the effect of the Mediterranean 
<br></span><span style="font-family: Arial; font-size:9px">Diet on cardiovascular diseases. He is the coordinator and a member of the Steering Committee of the 
<br>PREDIMED-PLUS STUDY, a multi-centre, randomised, primary prevention trial on 6000 overweight or obese 
<br>participants (55-75 years) with metabolic syndrome. The project aim is to determine the effect on adiposity, 
<br>cardiovascular disease and mortality and quality of life, of an intensive weight loss intervention based on a 
<br>traditional hypocaloric Mediterranean Diet, physical activity promotion and behavioural therapy compared to a 
<br>less intensive program using Mediterranean diet (without energy restriction or physical activity). The recruitment 
<br>started in September 2013 and will finish in June 2016. Final results will be available in 2020.  Since 1983 Dr. 
<br>Salas has directed 18 research projects financed by public bodies and 23 projects in conjunction with the 
<br>pharmaceutical or food industries. He has published more than 290 original articles in national and international 
<br>journals, as well as numerous reviews and editorials. Editor of 6 books, he has also co-authored more than 50 
<br>books. 
<br> 
<br></span><span style="font-family: Arial,BoldItalic; font-size:11px">The Mediterranean diet in diabetes 
<br></span><span style="font-family: Arial,Italic; font-size:8px">Jordi Salas Salvadó</span><span style="font-family: Arial,Italic; font-size:5px">a</span><span style="font-family: Arial,Italic; font-size:8px"> for the PREDIMED – Plus study investigators</span><span style="font-family: Arial; font-size:8px"> 
<br></span><span style="font-family: Arial,Italic; font-size:5px">a</span><span style="font-family: Arial,Italic; font-size:8px">Human Nutrition Unit, Hospital Universitari de Sant Joan de Reus, Faculty of Medicine and Health Sciences, IISPV (Institut 
<br>d’Investigació Sanitària Pere Virgili), Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, Reus, Spain, 
<br>and b CIBERobn (Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición), Institute of Health 
<br>Carlos III, Madrid, Spain. 
<br></span><span style="font-family: Arial; font-size:4px"> 
<br></span><span style="font-family: Arial; font-size:9px">There are no large randomized clinical trials in overweight subjects evaluating the effect of a long-term sustained 
<br>intentional weight loss using a healthy diet and physical activity promotion on the risk of cardiovascular clinical 
<br>events.  The PREDIMED Plus study is a randomized, multicenter, parallel-group trial for the primary prevention 
<br></span><span style="font-family: Arial; font-size:9px">of cardiovascular disease (CVD). Six thousand men and woman without prior CVD, aged between 55 – 75 
<br>years, with metabolic syndrome and body mass index between 27- 40 kg/m</span><span style="font-family: Arial; font-size:6px">2 </span><span style="font-family: Arial; font-size:9px">(&lt;25% of them with diabetes) will 
<br>be recruited by primary care medical doctors affiliated to 22 centers throughout Spain to evaluate the effect of an 
<br>intensive energy-restricted Mediterranean diet, physical activity promotion and behavioral treatment, versus a 
<br>control group receiving low-intensity recommendations to follow a Mediterranean diet. The mail outcomes are: 
<br>incidence of CVD, weight loss and maintenance, quality of life, incidence of other chronic diseases related to 
<br>obesity, changes in CVD risk factors, and use of medication. The results of this novel clinical trial will contribute 
<br>to provide a strong evidence to develop guidelines for overweight management aimed to the primary prevention 
<br>of CVD. 
<br></span><span style="font-family: Arial,Italic; font-size:4px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:252px; top:691px; width:110px; height:10px;"><span style="font-family: Arial,Bold; font-size:10px">Learning objectives:</span><span style="font-family: Arial,BoldItalic; font-size:10px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:704px; width:442px; height:9px;"><span style="font-family: Arial; font-size:9px">1.  Cross-sectional and prospective studies showed negative associations between some traditional 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:70px; top:716px; width:378px; height:9px;"><span style="font-family: Arial; font-size:9px">Mediterranean foods or adherence to the Mediterranean diet and diabetes incidence. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:727px; width:480px; height:9px;"><span style="font-family: Arial; font-size:9px">2.  The PREDIMED trial provided strong evidence that a vegetable-based MeDiet rich in unsaturated fat and 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:70px; top:739px; width:331px; height:9px;"><span style="font-family: Arial; font-size:9px">polyphenols can be a sustainable and ideal model for diabetes prevention. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:750px; width:494px; height:9px;"><span style="font-family: Arial; font-size:9px">3.  Randomized trials showed beneficial effects of the Mediterranean diet compared to other dietary patterns on 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:70px; top:762px; width:186px; height:9px;"><span style="font-family: Arial; font-size:9px">glycemic control in patients with diabetes. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:773px; width:0px; height:1px;"><span style="font-family: ABCDEE+Arial Bold,Bold; font-size:1px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:781px; width:8px; height:24px;"><span style="font-family: ABCDEE+Calibri; font-size:11px">4 
<br> 
<br></span></div><span style="position:absolute; border: black 1px solid; left:50px; top:688px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:688px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:51px; top:688px; width:509px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:688px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:688px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:688px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:688px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:702px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:702px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:714px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:714px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:725px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:725px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:737px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:737px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:748px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:748px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:772px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:772px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:51px; top:772px; width:509px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:772px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:772px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:760px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:760px; width:0px; height:12px;"></span>
<div style="position:absolute; border: figure 1px solid; writing-mode:False; left:55px; top:179px; width:97px; height:111px;"><div style="position:absolute; border: figure 1px solid; writing-mode:False; left:42px; top:179px; width:128px; height:163px;"></div></div><span style="position:absolute; border: black 1px solid; left:54px; top:178px; width:97px; height:111px;"></span>
<div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
